Medicare Part D - McKnight's Long Term Care News

Medicare Part D

Medicare drug pricing order could have ‘significant ramifications’ on LTC pharmacies in long run: expert

Long-term care pharmacies could soon be facing “significant ramifications in the long run” following an executive order signed by President Trump on Sunday. That directive states that the Medicare program should not pay more for Part D prescription drugs than the lowest price. More still needs to be known about possible effects, experts caution.

Clinical Briefs for Thursday, August 6

Proposed 9% cuts to therapy ‘potentially devastating’ … Medicare Part D favors generic drugs, say investigators … Novavax finds promising results in coronavirus vaccine trials … Bisphosphonates may reduce knee osteoarthritis … Heart disease meds underused among Hispanic/Latino populations with peripheral artery disease

Next post in News